Cargando…
Epigenetic Regulation of the Non-Coding Genome: Opportunities for Immuno-Oncology
The contribution of the non-coding genome to disease and its therapeutic potential have been largely unexplored. Recently, several epigenetic drugs developed for cancer treatment have been described to mediate therapeutic effects through the reactivation of the expression of transposable elements in...
Autor principal: | Barrero, Maria J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594693/ https://www.ncbi.nlm.nih.gov/pubmed/34968293 http://dx.doi.org/10.3390/epigenomes4030022 |
Ejemplares similares
-
Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018) -
What nature has to offer: Opportunities for immuno-oncology
por: Kousar, Rubina, et al.
Publicado: (2023) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017) -
Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021) -
Identification of continued challenges and opportunities in oncologists' comprehension of immuno-oncology
por: Herrmann, Tara, et al.
Publicado: (2015)